Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites-Reference-Cited by-同舟云学术

Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites

Published:2022-10-15 Issue: Volume:2022 Page:1-5
ISSN:2090-665X
Container-title:Case Reports in Nephrology
language:en
Short-container-title:Case Reports in Nephrology

Author:

Hayasaka Hideyuki¹,Ito Kiyonori²,Ookawara Susumu²^ORCID,Kofuji Masaya¹,Uchida Takayuki¹,Kawamura Shunto³,Gomyo Ayumi³,Miyazawa Haruhisa²,Ueda Yuichiro²,Hirai Keiji²,Kimura Shun-ichi³,Momose Naoki¹,Kako Shinichi³,Morishita Yoshiyuki²

Affiliation:

1. Department of Clinical Engineering, Saitama Medical Center, Jichi Medical University, Saitama, Japan

2. Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan

3. Division of Hematology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan

Abstract

A 60-year-old woman with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome and intractable ascites presented with acute renal failure and received hemodialysis (HD) therapy. Due to frequent intradialytic hypotension, ultrafiltration with cell-free and concentrated ascites reinfusion therapy (CART) was performed to adequately manage the body fluid status and massive ascites. During HD with CART, her blood pressure was maintained compared with that during HD without CART, and an ultrafiltration volume of 3.7 L was achieved after HD with CART. In HD patients with intradialytic hypotension and massive ascites, the combination of CART and ultrafiltration during HD may be an effective therapeutic option for body-fluid management.

Funder

Jichi Medical University

Publisher

Hindawi Limited

Subject

Nephrology

Link

http://downloads.hindawi.com/journals/crin/2022/7099227.pdf

Reference17 articles.

1. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients

2. Dry weight targeting: The art and science of conventional hemodialysis

3. EFFICACY OF CELL-FREE AND CONCENTRATED ASCITES FOR AUTOLOGOUS ALBUMIN PRODUCTS

4. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites

5. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1